From May 15-17 at booth 28, where we will be showcasing our Parsortix® technology and new Portrait®+ CTC staining kit*.
Category: Uncategorized
New Androgen Receptor assay now in development
A new agreement with a major global pharmaceutical company to develop a Parsortix® CTC based Androgen Receptor (AR) assay for use in prostate cancer studies.
Come see us at the 4th Clinical Biomarkers & Clinical Diagnostics Europe
Visit our booth to learn how we offer a bespoke service with molecular and imaging CTC assays customised to your requirements.
Novel methodology for CTC micronuclei detection
Working in partnership with a major global biopharmaceutical provider, we will be tailoring our existing Parsortix-based DNA damage response (DDR) assay for use in pharmaceutical R&D.
Come see us at AACR 2024
On booth 3054 where we’ll be showcasing our Parsortix® technology and new Portrait®+ CTC staining kits at the San Diego Convention Centre.
New poster!
Precision Medicine Poster Session at EBCC where we have two posters on display at poster board PB-117 & PB-123.
Portrait®+ CTC Staining Kits Now Available
We are excited to share that our first lot of Portrait+ CTC Staining Kits are packed and ready to go out to our customers.
Come see us at the Next-Gen Immuno-Oncology Conference
Anne-Sophie Pailhes-Jimenez, Senior Director, Head of R&D talks at 10:00-10:30 discussing PD-L1 expression in cancer cells from metastatic cancer patients.
Come see us at the 8th Liquid Biopsy for Precision Oncology Summit
Connect with us to learn about the power of Parsortix® technology and our clinical laboratory and to discover how we can support your clinical studies.
Company Team Building Day
It is great to have so many of our friends and colleagues together to strengthen inter-department relationships.